# Pilot Study on Trametinib for Surgical Unruptured AVMs

> **NCT06098872** · PHASE2 · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 10 (estimated)

## Conditions studied

- Arteriovenous Malformations

## Interventions

- **DRUG:** Trametinib tablet

## Key facts

- **NCT ID:** NCT06098872
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-30
- **Primary completion:** 2025-11
- **Final completion:** 2025-11
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06098872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06098872, "Pilot Study on Trametinib for Surgical Unruptured AVMs". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06098872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*